JNK2 shRNA expressing clones (M-2–12 and M-2–24; 11 (11 out of 13) tended to establish orthotopic pancreatic tumors more often than Neo-17 (4 out of 10; Fisher Exact test: p = 0.039). This evidence concerns the gene MAPK9 and pancreatic neoplasm.